Indivior Pharmaceuticals (INDV) Cash from Investing Activities (2024 - 2026)

Indivior Pharmaceuticals' Cash from Investing Activities history runs 3 years deep, the most recent figure standing at -$19.0 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 280.0% year-over-year to -$19.0 million; the TTM figure through Mar 2026 stood at -$80.0 million (down 305.13% YoY), while the FY2025 annual figure was -$66.0 million, down 195.65% from the prior year.
• Cash from Investing Activities was -$19.0 million for Q1 2026 at Indivior Pharmaceuticals, up from -$24.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $35.0 million in Q3 2024 to a low of -$24.0 million in Q4 2025.
• Historically, Cash from Investing Activities has averaged -$1.8 million across 3 years, with a median of -$5.0 million in 2025.
• Biggest YoY gain for Cash from Investing Activities was 120.0% in 2025; the steepest drop was 1800.0% in 2025.
• A 3-year view of Cash from Investing Activities shows it stood at $8.0 million in 2024, then sank by 400.0% to -$24.0 million in 2025, then rose by 20.83% to -$19.0 million in 2026.
• The last three Cash from Investing Activities figures came in at -$19.0 million (Q1 2026), -$24.0 million (Q4 2025), and -$20.0 million (Q3 2025), per Business Quant data.